Decrementally cost-effective health technologies in non-inferiority studies: A systematic review.
Ontology highlight
ABSTRACT: Background: HTA guidance has generally been driven by situations where innovative and usually more expensive technologies are compared to the prevailing standards of care. Cheaper and less efficacious interventions have received scarce attention, although strategies with minimal individual efficacy losses might produce collective health gains when savings are redistributed. Purpose: This systematic review of health economic evaluations identified interventions that are both cost and outcome reducing to procure a list of candidate decrementally cost-effective technologies. Data Sources: English language searches were performed in PubMed, EMBASE and ClinicalTrials.gov covering 2005 to September 2021. Study Selection: Full economic evaluations reporting in English
SUBMITTER: Darlington M
PROVIDER: S-EPMC9760952 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA